|
|
|
TB0196 |
Bio Basic |
500g |
EUR 86.1 |
- Product category: Electrophoresis Related/Reagents
|
Expedeon Biotech Inc. Laboratories manufactures the covcheckhctxnet reagents distributed by Genprice. The Covcheckhctxnet reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Expedeon Biotech Inc.. Other Covcheckhctxnet products are available in stock. Specificity: Covcheckhctxnet Category:
True Blue |
|
TargetMol Chemicals |
1mg |
Ask for price |
- SMILES: N=C(C1=CC=C(OC(/C=C/C2=CC3=CC(C(N)=N)=CC=C3O2)=C4)C4=C1)N.Cl.Cl
- Formula: C20H18Cl2N4O2
|
|
Description: True Blue |
True Blue |
|
TargetMol Chemicals |
50mg |
Ask for price |
- SMILES: N=C(C1=CC=C(OC(/C=C/C2=CC3=CC(C(N)=N)=CC=C3O2)=C4)C4=C1)N.Cl.Cl
- Formula: C20H18Cl2N4O2
|
|
Description: True Blue |
True Blue |
|
TargetMol Chemicals |
5mg |
Ask for price |
- SMILES: N=C(C1=CC=C(OC(/C=C/C2=CC3=CC(C(N)=N)=CC=C3O2)=C4)C4=C1)N.Cl.Cl
- Formula: C20H18Cl2N4O2
|
|
Description: True Blue |
JBS True Blue |
|
MiTeGen |
300 µl |
EUR 16 |
|
Description: JBS True Blue |
Test Assays information
CoV-2 S1 (319-541), Sf9 |
|
sars-049 |
ProSpec Tany |
2µg |
EUR 60 |
|
Description: Recombinant Coronavirus 2019-nCoV Spike Glycoprotein-S1 Receptor Binding Domain (319-541 a.a.), SF9 |
COV362 |
|
ABC-TC5589 |
AcceGen |
1 vial |
Ask for price |
|
Description: A human ovarian epithelial-endometroid carcinoma cell line established from a pleural effusion. Anchorage-independent growth in agar has been reported. The cell line COV362.4 is a subclone of this cell line. |
COV434 |
|
ABC-TC0191 |
AcceGen |
1 vial |
Ask for price |
|
Description: Human ovarian granulosa tumour. Human ovarian granulosa tumour cell line established from a solid primary tumour. |
COV644 |
|
ABC-TC0192 |
AcceGen |
1 vial |
Ask for price |
|
Description: Human ovarian epithelial-mucinous carcinoma, primary tumour. Human ovarian epithelial-mucinous carcinoma cell line established from a solid primary tumour. Anchorage-independent growth in agar has been reported. |
CoV-229E |
|
sars-001 |
ProSpec Tany |
100µg |
EUR 165 |
|
Description: Recombinant Coronavirus 229E |
CoV-2 S1 (16-685), Biotin |
|
sars-028 |
ProSpec Tany |
1µg |
EUR 100 |
|
Description: Recombinant Coronavirus 2019-nCoV Spike Glycoprotein-S1 (16-685 a.a.), Biotin |
CoV-2 S1 (319-541), Biotin |
|
sars-030 |
ProSpec Tany |
1µg |
EUR 100 |
|
Description: Recombinant Coronavirus 2019-nCoV Spike Glycoprotein-S1 Receptor Binding Domain (319-541 a.a.), Biotin |
CoV-2 N (1-419), Biotin |
|
sars-036 |
ProSpec Tany |
1µg |
EUR 100 |
|
Description: Recombinant Coronavirus 2019 Nucleocapsid (1-419 a.a.), Biotinylated |
CoV-2 N (196 a.a.) |
|
sars-042 |
ProSpec Tany |
50µg |
EUR 165 |
|
Description: Recombinant Coronavirus 2019 Nucleocapsid ( 196 a.a.) |
CoV-2 N (127 a.a.) |
|
sars-043 |
ProSpec Tany |
50µg |
EUR 165 |
|
Description: Recombinant Coronavirus 2019 Nucleocapsid ( 127 a.a.) |
CoV-2 N (329 a.a.) |
|
sars-044 |
ProSpec Tany |
50µg |
EUR 165 |
|
Description: Recombinant Coronavirus 2019 Nucleocapsid ( 329 a.a.) |
SARS CoV-2 IgG Spike S1 (CoV-2 IgG S1) Antibody |
|
abx137719-100tests |
Abbexa |
100 tests |
EUR 1237.5 |
SARS CoV-2 IgG Spike S1 (CoV-2 IgG S1) Antibody |
|
abx137720-100tests |
Abbexa |
100 tests |
EUR 1237.5 |
SARS CoV-2 IgM Spike S1 (CoV-2 IgM S1) Antibody |
|
abx137721-100tests |
Abbexa |
100 tests |
EUR 225 |
COV-19 tested |
|
RD100 |
GeneOn |
100 preps |
EUR 174 |
